Public Joint-Stock Company Pharmacy Chain 36.6 (APTK.ME)
RUB 12.5
(-0.03%)
RUB 12.5
(-0.03%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.59 Billion | 3.22 Billion | -3.36 Billion | -1.78 Billion | -9.19 Billion | -11.13 Billion |
| Net Income | 411 Million | -1.44 Billion | 6.77 Billion | -8.74 Billion | -22.97 Billion | -13.09 Billion |
| Depreciation & Amortization | 5.78 Billion | 5.8 Billion | 5.34 Billion | 5.15 Billion | 5.48 Billion | 1.49 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 527 Million | 1.07 Billion | -5.46 Billion | -1.73 Billion | -6.01 Billion | -5.55 Billion |
| Other non-cash items | -132 Million | -2.21 Billion | -10.01 Billion | 3.54 Billion | 30.97 Billion | 13.95 Billion |
| Investing Cash Flow | -995 Million | 18.28 Billion | -20.61 Billion | -2.44 Billion | -739 Million | -780 Million |
| Investments in PPE | -1.03 Billion | -981 Million | -1.92 Billion | -2.02 Billion | -822 Million | -459 Million |
| Acquisitions | -291 Million | 7.81 Billion | -191 Million | - | - | -84 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 331 Million | 11.44 Billion | -18.5 Billion | -424 Million | 83 Million | -237 Million |
| Financing Cash Flow | -6.51 Billion | -20.78 Billion | 24.14 Billion | 4.57 Billion | 9.77 Billion | 11.98 Billion |
| Debt repayment | -8.5 Billion | -16.83 Billion | -21.59 Billion | -41.01 Billion | -9.77 Billion | -11.81 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11.5 Billion | 22.1 Billion | - | 176 Million |
| Other Financing Activities | 1.98 Billion | -3.95 Billion | 34.23 Billion | 23.48 Billion | 14.87 Billion | 176 Million |
| Accounts receivables | 6 Million | -6 Million | -3.93 Billion | -1.86 Billion | 881 Million | -2.97 Billion |
| Accounts payables | -6 Million | 6 Million | -1.22 Billion | 1.79 Billion | -6.98 Billion | -944 Million |
| Inventory | -1.77 Billion | -1.18 Billion | -617 Million | -843 Million | 403 Million | -1.02 Billion |
| Other working capital | 2.3 Billion | 2.25 Billion | 306 Million | -820 Million | -306 Million | -620 Million |
| Cash at beginning of period | 1.72 Billion | 1 Billion | 847 Million | 503 Million | 659 Million | 585 Million |
| Cash at end of period | 811 Million | 1.72 Billion | 1 Billion | 847 Million | 503 Million | 659 Million |
| Capital Expenditure | -1.03 Billion | -981 Million | -1.92 Billion | -2.02 Billion | -822 Million | -459 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -916 Million | 724 Million | 156 Million | 344 Million | -156 Million | 74 Million |
| Free Cash Flow | 5.56 Billion | 2.24 Billion | -5.28 Billion | -3.8 Billion | -10.01 Billion | -11.59 Billion |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 43.5 Thousand | 43.5 Thousand | - | 411 Million | 238.5 Million | 238.5 Million |
| Depreciation & Amortization | 1.51 Million | 1.51 Million | - | 5.78 Billion | 1.52 Billion | 1.52 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -258 Thousand | -258 Thousand | - | 527 Million | -577 Million | -577 Million |
| Other non-cash items | -591 Thousand | -591 Thousand | - | -132 Million | -1.95 Billion | -1.95 Billion |
| Investing Cash Flow | 480.5 Thousand | 480.5 Thousand | - | -995 Million | 563.5 Million | 563.5 Million |
| Investments in PPE | -196.5 Thousand | -196.5 Thousand | - | -1.03 Billion | -183 Million | -183 Million |
| Acquisitions | -100 Thousand | -100 Thousand | - | -291 Million | 53 Million | 53 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 777 Thousand | 777 Thousand | - | 331 Million | 693.5 Million | 693.5 Million |
| Financing Cash Flow | -1.33 Million | -1.33 Million | - | -6.51 Billion | -111 Million | -111 Million |
| Debt repayment | - | - | - | -8.5 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -150 Thousand | -150 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.18 Million | -1.18 Million | - | 1.98 Billion | -111 Million | -111 Million |
| Accounts receivables | - | - | - | 6 Million | 3 Million | 3 Million |
| Accounts payables | - | - | - | -6 Million | - | - |
| Inventory | -76 Thousand | -76 Thousand | - | -1.77 Billion | -338.5 Million | -338.5 Million |
| Other working capital | -182 Thousand | -182 Thousand | - | 2.3 Billion | -241.5 Million | -241.5 Million |
| Cash at beginning of period | -144.85 Million | -144.85 Million | - | 1.72 Billion | - | - |
| Cash at end of period | -145 Million | -145 Million | - | 811 Million | 1.08 Billion | -320.5 Million |
| Capital Expenditure | -196.5 Thousand | -196.5 Thousand | - | -1.03 Billion | -183 Million | -183 Million |
| Effect of forex changes on cash | - | - | - | - | 1.4 Billion | - |
| Net cash flow / Change in cash | -145 Thousand | -145 Thousand | - | -916 Million | 1.08 Billion | -320.5 Million |
| Free Cash Flow | 515.5 Thousand | 515.5 Thousand | - | 5.56 Billion | -956 Million | -956 Million |
CTMCF
ASCN
UDS
UNITEDTEA
GBLP
DMCOF